Please assess the completion status of the following clinical trial:

Trial Title: OPSCC N0 Nodal Control With Reduced IMRT

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* patient must be clinically referred for radiation for stage I-IVb OPSCCA~* tumor must be HPV-associated p16+~* patient must be able to lie flat and tolerate immobilization systems~Exclusion Criteria:~* patients may not be receiving any investigational agents~* prior radiation to head and neck~* any other malignancy except non-melanomatous skin cancer or a carcinoma not of head and neck origin with patient being disease free for at least 5 years~* any major medical, psychiatric, or neurologic illness~* pregnant or breastfeeding women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Reduced Intensity Radiation (Type: EXPERIMENTAL): 39.6 Gy radiation to clinically uninvolved cervical lymphatics

Based on this trial design, predict the completion outcome and termination type (if applicable).